ANEB - Anebulo Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ANEB is currently covered by 1 analysts with an average price target of $4.72. This is a potential upside of $3.58 (314.04%) from yesterday's end of day stock price of $1.14.

Anebulo Pharmaceuticals's activity chart (see below) currently has 8 price targets and 9 ratings on display. The stock rating distribution of ANEB is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 16.67% with an average time for these price targets to be met of 23 days.

Highest price target for ANEB is $3, Lowest price target is $3, average price target is $3.

Most recent stock forecast was given by MICHAEL OKUNEWITCH from MAXIM GROUP on 15-May-2025. First documented stock forecast 14-Feb-2023.

Best performing analysts who are covering ANEB - Anebulo Pharmaceuticals:

Robert Wasserman Raghuram Selvaraju Michael Okunewitch

Currently out of the existing stock ratings of ANEB, 1 are a BUY (100%).

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

Since 21-Sep-2023

$3

$1.86 (163.16%)

$6

7 months 27 days ago
(15-May-2025)

1/2 (50%)

$1.99 (197.03%)

69

Buy

Since 14-Feb-2023

$8

1 years 1 months 23 days ago
(19-Nov-2024)

0/4 (0%)

$6.02 (304.04%)

Buy

Since 18-Sep-2023

$6

$4.86 (426.32%)

$6

2 years 3 months 17 days ago
(25-Sep-2023)

0/2 (0%)

$2.73 (83.49%)

Show more analysts

Please expand the browser size to see the chart

What is ANEB (Anebulo Pharmaceuticals) average time for price targets to be met?

On average it took 23 days on average for the stock forecasts to be realized with a an average price target met ratio 16.67

Which analyst has the current highest performing score on ANEB (Anebulo Pharmaceuticals) with a proven track record?

ROBERT WASSERMAN

Which analyst has the current lower performing score on ANEB (Anebulo Pharmaceuticals) with a proven track record?

MICHAEL OKUNEWITCH

Which analyst has the most public recommendations on ANEB (Anebulo Pharmaceuticals)?

Robert Wasserman works at BENCHMARK and has 7 price targets and 6 ratings on ANEB

Which analyst is the currently most bullish on ANEB (Anebulo Pharmaceuticals)?

Raghuram Selvaraju with highest potential upside - $4.86

Which analyst is the currently most reserved on ANEB (Anebulo Pharmaceuticals)?

Robert Wasserman with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?